Clinical Trials Browser

Phase 2 × OTHER_GOV × XELOX × Clear all

NCT06227325 2024-01-26

Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

NCT01952951 2017-09-13

PREPARE

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Rectal Neoplasms